Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rodenhuis

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|April 21, 1995
Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancerB Top, W J Mooi, S G Klaver, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 30, 1993
[Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy]D J Richel, J W Baars, M J Wijngaarden, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1984
Patient motivation and informed consent in a phase I study of an anticancer agentS Rodenhuis, W J van den Heuvel, A A Annyas, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 24, 2000
Simple and selective determination of the cyclophosphamide metabolite phosphoramide mustard in human plasma using high-performance liquid chromatographyA D Huitema, M M Tibben, T Kerbusch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepaS Rodenhuis, J W Baars, J H Schornagel, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Determination of N,N',N"-triethylenethiophosphoramide and its active metabolite N,N',N"-triethylenephosphoramide in plasma and urine using capillary gas chromatographyR J van Maanen, R D van Ooijen, J W Zwikker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1994
Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheterL T Vlasveld, S Rodenhuis, E J Rutgers, et al.
Bone Marrow Transplantation|October 31, 2002
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapyM E de Jonge, R A A Mathôt, O Dalesio, et al.
British Journal of Cancer|February 6, 2003
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcomeI F Faneyte, J G Schrama, J L Peterse, et al.
The New England Journal of Medicine|October 8, 1987
Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lungS Rodenhuis, M L van de Wetering, W J Mooi, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|April 21, 1995
Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancerB Top, W J Mooi, S G Klaver, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 30, 1993
[Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy]D J Richel, J W Baars, M J Wijngaarden, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1984
Patient motivation and informed consent in a phase I study of an anticancer agentS Rodenhuis, W J van den Heuvel, A A Annyas, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 24, 2000
Simple and selective determination of the cyclophosphamide metabolite phosphoramide mustard in human plasma using high-performance liquid chromatographyA D Huitema, M M Tibben, T Kerbusch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepaS Rodenhuis, J W Baars, J H Schornagel, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Determination of N,N',N"-triethylenethiophosphoramide and its active metabolite N,N',N"-triethylenephosphoramide in plasma and urine using capillary gas chromatographyR J van Maanen, R D van Ooijen, J W Zwikker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1994
Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheterL T Vlasveld, S Rodenhuis, E J Rutgers, et al.
Bone Marrow Transplantation|October 31, 2002
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapyM E de Jonge, R A A Mathôt, O Dalesio, et al.
British Journal of Cancer|February 6, 2003
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcomeI F Faneyte, J G Schrama, J L Peterse, et al.
The New England Journal of Medicine|October 8, 1987
Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lungS Rodenhuis, M L van de Wetering, W J Mooi, et al.
Pageof 15